Home
       
  HOME  


  Press releases - Corporate Sites
Select Stock Market:
All Abu Dhabi Amsterdam BATS Bombay Brussels Burgundy Chi-X Copenhagen Dubai Dublin Frankfurt
Hanoi Helsinki HoChiMinh Hong Kong Iceland Lisbon London Madrid Milan Moscow Moscow Classica
Nasdaq NSE (India) NYSE NYSE MKT Oslo Paris Riga Shanghai Stockholm Tallinn Tokyo
Toronto TSX Venture Tunis USOTC Warsaw Vienna Vilnius XETRA Zurich
Select Period:                 Order by:
All Today Yesterday Last week Last month Date Company
 


2024-05-17 
KYOWA KIRIN CO., LTD. : Kyowa Kirin Announces Approval for Partial Change of Approved Indication of G-Lasta® for the Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Blood Stem Cell Transplantation in Japan
2024-05-15 
EISAI CO., LTD. : Eisai Announces Acquisition of Own Shares and Cancellation of Treasury Shares Acquisition of own shares pursuant to the provision of its Articles of Incorporation in accordance with Article 459, paragraph 1 of the Companies Act and cancellation of treasury shares pursuant to the provisions of Article 178 of the Companies Act
2024-05-15 
EISAI CO., LTD. : Notice of Nominees for Directors and Corporate Officers
2024-05-15 
EISAI CO., LTD. : Notice Concerning Appointment of New Representative Officer
2024-05-15 
EISAI CO., LTD. : Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
2024-05-14 
KYOWA KIRIN CO., LTD. : CTCL Global Care Collaborative Pioneers Consensus for Improving Diagnosis and Care in Cutaneous T-Cell Lymphoma (CTCL)
2024-05-14 
DAIICHI SANKYO CO., LTD. : Daiichi Sankyo Announces Appointments of Directors(251.4KB)
2024-05-14 
KONAMI GROUP CORPORATION : Announcement Concerning Resolution on Acquisition of Treasury Stock
2024-05-14 
KONAMI GROUP CORPORATION : Announcement of Revision of Consolidated Financial Forecasts for the Six Months Ending June 30, 2024 and the Fiscal Year Ending December 31, 2024
2024-05-14 
KONAMI GROUP CORPORATION : Financial Results for the three months ended March 31, 2024 Support Material
2024-05-14 
KONAMI GROUP CORPORATION : Consolidated Financial Results for the Three Months ended March 31, 2024 [IFRS]
2024-05-13 
TOYOBO CO., LTD. : 2025 Medium-Term Management Plan (FY 3/23 - FY 3/26) ~ Review of the first half and action in the second half ~ (1MB)
2024-05-13 
TOYOBO CO., LTD. : Notice of Difference between Consolidated Earnings Forecasts and Actual Results for the Fiscal Year Ended March 2024 Toyobo (113KB)
2024-05-13 
TOYOBO CO., LTD. : Presentation to Investors for Year Ended March 31, 2024 (328KB)
2024-05-13 
TOYOBO CO., LTD. : Consolidated Financial Report for Year Ended March 31, 2024 (308KB)
2024-05-13 
EISAI CO., LTD. : ANTIEPILEPTIC DRUG FYCOMPA® APPROVED IN CHINA FOR ADJUNCTIVE TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES



   2024      2023      2022      2021      2020      2019      2018      2017      2016      2015      2014      2013      2012      2011      2010      2009      2008      2007      2006      2005      2004      2003      2002      2001      2000  
Back